Molecular mechanisms in malignant lymphoma


The goal of this project is the molecular and genomic characterization of B-cell lymphoma. In combination with clinical and histopathological data, a better understanding of lymphomagenesis and lymphoma classification will be achieved.


During 2003 and 2011 the german cancer aid funded the molecular mechanisms in malignant lymphomas (MMML) project. It is based on strongly interacting networks of reference pathologists, lymphoma scientists, bioinformaticians and clinical trial groups. Within the project about 1000 lymphoma samples and controls were characterized by gene expression and copy number arrays. The datasets were supplemented by extensive histopathological and clinical descriptions of the lymphoma cases. The aim of the project was a detailed characterization of the molecular basis of lymphoma development and progression.

Programme: This Project is not associated with a Programme


Funding codes:
  • German Cancer Aid

Public web page: Not specified

Organisms: No Organisms specified

Human Diseases: Non-hodgkin lymphoma

Health Atlas PALs: Markus Löffler

Project Coordinators: No Project coordinators for this Project

Project created: 8th May 2019

Project Hierarchy

Related items

Powered by
Copyright © 2008 - 2020 The University of Manchester and HITS gGmbH
Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig